UBS AM
NOVT icon

UBS AM’s Novanta NOVT Stock Holding History

UBS AM’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Sell
92,426
-2,655
-3% -$384K ﹤0.01% 1057
2026
Q1 		$11.2M Buy
95,081
+406
+0.4% +$53.3K ﹤0.01% 1134
2025
Q4 		$11.3M Buy
94,675
+998
+1% +$114K ﹤0.01% 1071
2025
Q3 		$9.38M Buy
93,677
+57,766
+161% +$6.88M ﹤0.01% 1089
2025
Q2 		$4.63M Sell
35,911
-5,106
-12% -$621K ﹤0.01% 1748
2025
Q1 		$5.24M Sell
41,017
-77,045
-65% -$11.1M ﹤0.01% 1548
2024
Q4 		$18M Buy
118,062
+17,803
+18% +$3.01M ﹤0.01% 1000
2024
Q3 		$17.9M Buy
100,259
+52,573
+110% +$9.14M ﹤0.01% 986
2024
Q2 		$7.78M Sell
47,686
-4,533
-9% -$735K ﹤0.01% 1250
2024
Q1 		$9.13M Buy
52,219
+4,246
+9% +$696K ﹤0.01% 1037
2023
Q4 		$8.08M Buy
47,973
+3,409
+8% +$497K ﹤0.01% 1070
2023
Q3 		$6.39M Buy
44,564
+2,443
+6% +$398K ﹤0.01% 1120
2023
Q2 		$6.7M Hold
42,121
– – ﹤0.01% 1109
2023
Q1 		$6.7M Buy
42,121
+108
+0.3% +$16.6K ﹤0.01% 1109
2022
Q4 		$5.71M Buy
42,013
+2,845
+7% +$398K ﹤0.01% 1125
2022
Q3 		$4.53M Sell
39,168
-7,023
-15% -$957K ﹤0.01% 1230
2022
Q2 		$5.6M Sell
46,191
-1,504
-3% -$189K ﹤0.01% 1173
2022
Q1 		$6.79M Buy
47,695
+3,840
+9% +$545K ﹤0.01% 1219
2021
Q4 		$7.73M Sell
43,855
-624
-1% -$104K ﹤0.01% 1224
2021
Q3 		$6.87M Buy
44,479
+1,448
+3% +$211K ﹤0.01% 1233
2021
Q2 		$5.8M Buy
43,031
+2,043
+5% +$275K ﹤0.01% 1303
2021
Q1 		$5.41M Hold
40,988
– – ﹤0.01% 1301
2020
Q4 		$4.85M Sell
40,988
-93
-0.2% -$10.8K ﹤0.01% 1307
2020
Q3 		$4.33M Buy
41,081
+2,114
+5% +$223K ﹤0.01% 1214
2020
Q2 		$4.16M Buy
38,967
+342
+0.9% +$31.8K ﹤0.01% 1195
2020
Q1 		$3.09M Buy
38,625
+3,594
+10% +$321K ﹤0.01% 1244
2019
Q4 		$3.1M Buy
35,031
+2,330
+7% +$201K ﹤0.01% 1401
2019
Q3 		$2.67M Buy
32,701
+4,349
+15% +$353K ﹤0.01% 1478
2019
Q2 		$2.67M Buy
28,352
+5,327
+23% +$455K ﹤0.01% 1442
2019
Q1 		$1.95M Sell
23,025
-1,476
-6% -$111K ﹤0.01% 1533
2018
Q4 		$1.54M Buy
24,501
+1,680
+7% +$108K ﹤0.01% 1542
2018
Q3 		$1.56M Buy
22,821
+4,092
+22% +$287K ﹤0.01% 1608
2018
Q2 		$1.17M Sell
18,729
-5,088
-21% -$311K ﹤0.01% 1755
2018
Q1 		$1.24M Buy
23,817
+3,885
+19% +$213K ﹤0.01% 1690
2017
Q4 		$997K Buy
19,932
+5,134
+35% +$250K ﹤0.01% 1754
2017
Q3 		$645K Buy
14,798
+1,500
+11% +$58.3K ﹤0.01% 1862
2017
Q2 		$479K Buy
13,298
+3,500
+36% +$111K ﹤0.01% 1898
2017
Q1 		$260K Hold
9,798
– – ﹤0.01% 2067
2016
Q4 		$206K Sell
9,798
-18,100
-65% -$345K ﹤0.01% 2115
2016
Q3 		$484K Hold
27,898
– – ﹤0.01% 1999
2016
Q2 		$423K Buy
+27,898
New +$429K ﹤0.01% 2043

Other funds holding NOVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

UBS AM's NOVT Position: Q2 2026 in Review

UBS AM reduced its Novanta (NOVT) stake by 2.8% in Q2 2026, selling an estimated $384K and leaving 92,426 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

UBS AM first reported a position in NOVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $18M in Q4 2024. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • UBS AM held 92,426 shares of Novanta worth $15M as of Q2 2026.
  • UBS AM sold 2,655 Novanta shares in Q2 2026, an estimated $384K.
  • Novanta made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1057 holding.
  • UBS AM first reported a position in Novanta in Q2 2016 and has held it in 41 quarters since.
  • UBS AM's Novanta position peaked at $18M in Q4 2024.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.